Overview

Safety Study to Evaluate the Cumulative Irritation Potential of Topically Applied ZuraPrep™ and ZuraPrep™ Without IPA

Status:
Completed
Trial end date:
2014-09-01
Target enrollment:
Participant gender:
Summary
This is a safety study to determine the cumulative skin irritation potential of ZuraPrep™ and ZuraPrep™ without Isopropyl Alcohol after repetitive patch applications to skin of human subjects.
Phase:
Phase 1
Details
Lead Sponsor:
Zurex Pharma, Inc.
Treatments:
Chlorhexidine
Chlorhexidine gluconate